NasdaqGS:SRCL

Stock Analysis Report

Executive Summary

Stericycle, Inc., together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally.

Snowflake

Fundamentals

Moderate growth potential and slightly overvalued.


Similar Companies

Share Price & News

How has Stericycle's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-1.3%

SRCL

1.4%

US Commercial Services

-0.6%

US Market


1 Year Return

-18.1%

SRCL

6.7%

US Commercial Services

0.7%

US Market

SRCL underperformed the Commercial Services industry which returned 6.7% over the past year.

SRCL underperformed the Market in United States of America which returned 0.6% over the past year.


Share holder returns

SRCLIndustryMarket
7 Day-1.3%1.4%-0.6%
30 Day13.0%2.1%2.9%
90 Day7.7%0.9%1.3%
1 Year-18.1%-18.1%10.7%6.7%2.9%0.7%
3 Year-36.7%-36.7%67.1%55.7%44.6%35.2%
5 Year-56.4%-56.4%102.4%82.3%61.9%44.2%

Price Volatility Vs. Market

How volatile is Stericycle's share price compared to the market and industry in the last 5 years?


Simply Wall St News

1 month ago | Simply Wall St

Is Stericycle (NASDAQ:SRCL) A Risky Investment?

Valuation

Is Stericycle undervalued based on future cash flows and its price relative to the stock market?

33%

Discount to future cash flow value


Intrinsic Value Based on Future Cash Flows

Stericycle's share price is below the future cash flow value, and at a moderate discount (> 20%).

Stericycle's share price is below the future cash flow value, but not at a substantial discount (< 40%).


Price Based on Earnings

Stericycle is loss making, we can't compare its value to the US Commercial Services industry average.

Stericycle is loss making, we can't compare the value of its earnings to the United States of America market.


Price Based on Expected Growth

Unable to calculate PEG ratio for Stericycle, we can't assess if its growth is good value.


Price Based on Value of Assets

Stericycle is good value based on assets compared to the US Commercial Services industry average.


Next Steps

Future Growth

How is Stericycle expected to perform in the next 1 to 3 years based on estimates from 11 analysts?

125.6%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Stericycle's revenue is expected to grow by 3.5% yearly, however this is not considered high growth (20% yearly).

Stericycle's earnings are expected to grow significantly at over 20% yearly.

Stericycle's revenue growth is positive but not above the United States of America market average.

Stericycle's earnings growth is expected to exceed the United States of America market average.

Stericycle's earnings growth is expected to exceed the low risk savings rate of 2.7%.


Earnings per Share Growth Estimates


Future Return on Equity

Unable to establish if Stericycle will efficiently use shareholders’ funds in the future without estimates of Return on Equity.


Next Steps

Past Performance

How has Stericycle performed over the past 5 years?

-55.0%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Stericycle does not make a profit and their year on year earnings growth rate was negative over the past 5 years.

Unable to compare Stericycle's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare Stericycle's 1-year growth to the US Commercial Services industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if Stericycle has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.


Return on Assets

It is difficult to establish if Stericycle has efficiently used its assets last year compared to the US Commercial Services industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if Stericycle improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is Stericycle's financial position?


Financial Position Analysis

Stericycle is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Stericycle's long term commitments exceed its cash and other short term assets.


Debt to Equity History and Analysis

Stericycle's level of debt (109.9%) compared to net worth is high (greater than 40%).

The level of debt compared to net worth has increased over the past 5 years (92.6% vs 109.9% today).

Debt is not well covered by operating cash flow (0.2%, less than 20% of total debt).

Stericycle is making a loss, therefore interest payments are not well covered by earnings.


Balance Sheet

Low level of unsold assets.

Debt is not covered by short term assets, assets are 0.3x debt.


Next Steps

Dividend

What is Stericycle's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Stericycle's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Stericycle's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Stericycle has not reported any payouts.

Unable to verify if Stericycle's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Stericycle has not reported any payouts.


Future Payout to Shareholders

No need to calculate the sustainability of Stericycle's dividends in 3 years as they are not expected to pay a notable one for United States of America.


Next Steps

Management

What is the CEO of Stericycle's salary, the management and board of directors tenure and is there insider trading?

0.7yrs

Average management tenure


CEO

Cindy Miller (56yo)

0.3yrs

Tenure

US$2,375,730

Compensation

Ms. Cindy J. Miller has been the President of Stericycle, Inc. since October 1, 2018, Chief Executive Officer since May 2, 2019 and as its Director since February 28, 2019. Ms. Miller served as Chief Opera ...


CEO Compensation Analysis

Cindy's remuneration is lower than average for companies of similar size in United States of America.

Insufficient data for Cindy to compare compensation growth.


Management Age and Tenure

0.7yrs

Average Tenure

55yo

Average Age

The average tenure for the Stericycle management team is less than 2 years, this suggests a new team.


Board Age and Tenure

1.4yrs

Average Tenure

64yo

Average Age

The average tenure for the Stericycle board of directors is less than 3 years, this suggests a new board.


Insider Trading

No 3 month open market individual insider trading information.


Ownership Breakdown


Management Team

  • Rich Hoffman (52yo)

    Senior VP & Chief Accounting Officer

    • Tenure: 2.3yrs
  • Kurt Rogers (47yo)

    Executive VP

    • Tenure: 2.2yrs
    • Compensation: US$1.00m
  • David Stahl (54yo)

    Executive VP & Chief Information Officer

    • Tenure: 1.4yrs
  • Dan Ginnetti (50yo)

    Executive Vice President of International

    • Tenure: 0.3yrs
    • Compensation: US$1.73m
  • Janet Zelenka (60yo)

    Executive VP & CFO

    • Tenure: 0.3yrs
  • Jennifer Koenig

    Vice President of Corporate Communications & Investor Relations

    • Tenure: 0yrs
  • Michael Weisman (60yo)

    Executive VP and Chief Ethics & Compliance Officer

    • Tenure: 1.4yrs
  • Cindy Miller (56yo)

    President

    • Tenure: 0.3yrs
    • Compensation: US$2.38m
  • Joe Reuter (57yo)

    Executive VP & Chief People Officer

    • Tenure: 0.7yrs
  • S. White

    Executive Vice President of Communication & Related Services

    • Tenure: 0.3yrs

Board Members

  • Mike Zafirovski (65yo)

    Director

    • Tenure: 6.8yrs
    • Compensation: US$185.00k
  • Thomas Chen (69yo)

    Director

    • Tenure: 5.3yrs
    • Compensation: US$185.00k
  • Brian Anderson (68yo)

    Director

    • Tenure: 2.7yrs
    • Compensation: US$200.00k
  • Ronee Hagen (73yo)

    Director

    • Tenure: 1.3yrs
    • Compensation: US$148.50k
  • Kay Priestly (63yo)

    Director

    • Tenure: 1.3yrs
    • Compensation: US$148.50k
  • Bob Murley (69yo)

    Chairman

    • Tenure: 1.5yrs
    • Compensation: US$260.00k
  • Steve Hooley (55yo)

    Director

    • Tenure: 0.5yrs
  • Lynn Bleil (56yo)

    Director

    • Tenure: 4.3yrs
    • Compensation: US$191.25k
  • J. Hackney (49yo)

    Director

    • Tenure: 0.5yrs
  • Cindy Miller (56yo)

    President

    • Tenure: 0.3yrs
    • Compensation: US$2.38m

Company Information

Stericycle, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Stericycle, Inc.
  • Ticker: SRCL
  • Exchange: NasdaqGS
  • Founded: 1989
  • Industry: Environmental and Facilities Services
  • Sector: Commercial Services
  • Market Cap: US$4.586b
  • Shares outstanding: 91.12m
  • Website: https://www.stericycle.com

Number of Employees


Location

  • Stericycle, Inc.
  • 28161 North Keith Drive
  • Lake Forest
  • Illinois
  • 60045
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
SRCLNasdaqGS (Nasdaq Global Select)YesCommon StockUSUSDAug 1996
SY9DB (Deutsche Boerse AG)YesCommon StockDEEURAug 1996
0L9OLSE (London Stock Exchange)YesCommon StockGBUSDAug 1996

Biography

Stericycle, Inc., together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It operates thro ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/21 23:45
End of Day Share Price2019/09/20 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.